Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model

Hyun Jin Tae, Natalia Petrashevskaya, Ismayil Ahmet, Sungha Park, Mark I. Talan, Edward G. Lakatta, Li Lin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: We aimed to assess the therapeutic efficacy of differentially modified soluble receptor for advanced glycation end products (sRAGE) in vivo using vessel ultrasound sonography and to compare the sonography data with those from postmortem histomorphologic analyses to have a practical reference for future clinical applications. Methods: Vessel ultrasound sonography was performed in a sRAGE-treated rat carotid artery balloon injury model at different time points after the surgery, and therapeutic efficacy of different doses of sRAGE produced in Chinese hamster ovary cells and with different N-glycoform modifications were assessed. Results: Vessel ultrasound sonography found that sRAGE produced in Chinese hamster ovary cells with complex N-glycoform modifications is highly effective, and is consistent with our recent findings in the same model assessed with histology. We also found that sonography is less sensitive than histology when a higher dose of sRAGE is administered. Conclusions: Sonograph results are consistent with those obtained from histology; that is, sRAGE produced in Chinese hamster ovary cells has significantly higher efficacy than insect cell-originated sRAGE cells.

Original languageEnglish
Pages (from-to)110-115
Number of pages6
JournalCurrent Therapeutic Research - Clinical and Experimental
Volume76
DOIs
Publication statusPublished - 2014 Dec 1

Fingerprint

Ultrasonography
Wounds and Injuries
Cricetulus
Ovary
Histology
Carotid Artery Injuries
Insects
Advanced Glycosylation End Product-Specific Receptor
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology

Cite this

Tae, Hyun Jin ; Petrashevskaya, Natalia ; Ahmet, Ismayil ; Park, Sungha ; Talan, Mark I. ; Lakatta, Edward G. ; Lin, Li. / Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model. In: Current Therapeutic Research - Clinical and Experimental. 2014 ; Vol. 76. pp. 110-115.
@article{2051097743ce43f7b5f9df26e67d3f32,
title = "Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model",
abstract = "Objective: We aimed to assess the therapeutic efficacy of differentially modified soluble receptor for advanced glycation end products (sRAGE) in vivo using vessel ultrasound sonography and to compare the sonography data with those from postmortem histomorphologic analyses to have a practical reference for future clinical applications. Methods: Vessel ultrasound sonography was performed in a sRAGE-treated rat carotid artery balloon injury model at different time points after the surgery, and therapeutic efficacy of different doses of sRAGE produced in Chinese hamster ovary cells and with different N-glycoform modifications were assessed. Results: Vessel ultrasound sonography found that sRAGE produced in Chinese hamster ovary cells with complex N-glycoform modifications is highly effective, and is consistent with our recent findings in the same model assessed with histology. We also found that sonography is less sensitive than histology when a higher dose of sRAGE is administered. Conclusions: Sonograph results are consistent with those obtained from histology; that is, sRAGE produced in Chinese hamster ovary cells has significantly higher efficacy than insect cell-originated sRAGE cells.",
author = "Tae, {Hyun Jin} and Natalia Petrashevskaya and Ismayil Ahmet and Sungha Park and Talan, {Mark I.} and Lakatta, {Edward G.} and Li Lin",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.curtheres.2014.08.001",
language = "English",
volume = "76",
pages = "110--115",
journal = "Current Therapeutic Research",
issn = "0011-393X",
publisher = "Excerpta Medica",

}

Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model. / Tae, Hyun Jin; Petrashevskaya, Natalia; Ahmet, Ismayil; Park, Sungha; Talan, Mark I.; Lakatta, Edward G.; Lin, Li.

In: Current Therapeutic Research - Clinical and Experimental, Vol. 76, 01.12.2014, p. 110-115.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model

AU - Tae, Hyun Jin

AU - Petrashevskaya, Natalia

AU - Ahmet, Ismayil

AU - Park, Sungha

AU - Talan, Mark I.

AU - Lakatta, Edward G.

AU - Lin, Li

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Objective: We aimed to assess the therapeutic efficacy of differentially modified soluble receptor for advanced glycation end products (sRAGE) in vivo using vessel ultrasound sonography and to compare the sonography data with those from postmortem histomorphologic analyses to have a practical reference for future clinical applications. Methods: Vessel ultrasound sonography was performed in a sRAGE-treated rat carotid artery balloon injury model at different time points after the surgery, and therapeutic efficacy of different doses of sRAGE produced in Chinese hamster ovary cells and with different N-glycoform modifications were assessed. Results: Vessel ultrasound sonography found that sRAGE produced in Chinese hamster ovary cells with complex N-glycoform modifications is highly effective, and is consistent with our recent findings in the same model assessed with histology. We also found that sonography is less sensitive than histology when a higher dose of sRAGE is administered. Conclusions: Sonograph results are consistent with those obtained from histology; that is, sRAGE produced in Chinese hamster ovary cells has significantly higher efficacy than insect cell-originated sRAGE cells.

AB - Objective: We aimed to assess the therapeutic efficacy of differentially modified soluble receptor for advanced glycation end products (sRAGE) in vivo using vessel ultrasound sonography and to compare the sonography data with those from postmortem histomorphologic analyses to have a practical reference for future clinical applications. Methods: Vessel ultrasound sonography was performed in a sRAGE-treated rat carotid artery balloon injury model at different time points after the surgery, and therapeutic efficacy of different doses of sRAGE produced in Chinese hamster ovary cells and with different N-glycoform modifications were assessed. Results: Vessel ultrasound sonography found that sRAGE produced in Chinese hamster ovary cells with complex N-glycoform modifications is highly effective, and is consistent with our recent findings in the same model assessed with histology. We also found that sonography is less sensitive than histology when a higher dose of sRAGE is administered. Conclusions: Sonograph results are consistent with those obtained from histology; that is, sRAGE produced in Chinese hamster ovary cells has significantly higher efficacy than insect cell-originated sRAGE cells.

UR - http://www.scopus.com/inward/record.url?scp=84909986900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909986900&partnerID=8YFLogxK

U2 - 10.1016/j.curtheres.2014.08.001

DO - 10.1016/j.curtheres.2014.08.001

M3 - Article

AN - SCOPUS:84909986900

VL - 76

SP - 110

EP - 115

JO - Current Therapeutic Research

JF - Current Therapeutic Research

SN - 0011-393X

ER -